FlexTouch^® is an innovative prefilled insulin pen from Novo Nordisk with no push-button extension. Read about the features of FlexTouch^®, designed to improve insulin delivery for patients.

0

0

Insulin detemir is indicated for the treatment of children aged two to five years with type 1 diabetes in the EU. This represents the first time such a treatment option is available in this patient population, where the risk of hypoglycaemia is an important consideration.

0

0

Each of your patients with diabetes is unique and their therapy needs to be individualised according to their specific needs. Learn more about tools to help you do this.

0

0

NovoMedLink is now available for instant access through your smartphone. Find out how the mobile-enabled version can support your information needs on demand.

0

0

Patients ' feelings will affect how well they accept new treatments. Providing the right therapy information at the right time could improve understanding and increase acceptance.

0

0

At diagnosis, the majority of patients with type 2 diabetes have already lost 50% of their beta-cell function. Learn about the effects of a human GLP-1 analogue on beta-cell function.

9

18

There are many factors that influence the choice of an insulin delivery system. Discover how modern insulin devices may be a better solution for your patients.

1

2

When metformin alone no longer provides adequate glycaemic control for patients with type 2 diabetes, traditional treatment calls for the addition of oral medications, then insulin.

3

4

Treating patients with type 2 diabetes is a balancing act between optimising glycaemic control while minimizing risk of hypoglycaemia. Learn about the efficacy and safety of a biphasic insulin analogue.

1

1

The benefits of an internet-based blood glucose monitoring system and how this may help to improve glycaemic control.

9

4

What's stopping your patients from starting insulin? Features of modern insulin pens & needles may overcoming barriers to intiating insulin.

23

15

Maintaining a healthy weight is important in treating type 2 diabetes and weight gain is a key concern for doctors and patients when initiating insulin therapy.

12

17